Diabetes complications

Clinical implications of a history of pre‐eclampsia in women with type two diabetes mellitus

Diabet MedPublished Nested case-control study

Main finding · Microvascular disease after T2D diagnosisResult — go to the resultHazard ratio 1.26 95% CI 1.12–1.42

Authors' conclusion

At T2D diagnosis, women with a PE history are younger, with more severe clinical presentations and increased risk of developing T2D microvascular complications. This highlights the crucial need for changes to the long-term care of this high-risk group, with aggressive risk-factor management and continued clinical assessment.

Study context

Population
Women with T2D and prior pregnancies (1921–2022), Scottish Care Information for Diabetes data, NHS Tayside and Fife, linked with Scottish maternity morbidity records
Participants
6,055 women
Comparison
Prior pre-eclampsia (PE) vs PE-free pregnancies
  • PEn = 726
  • PE-freen = 5,329reference
Outcome
Microvascular disease after T2D diagnosis
Methodological detailsrecord linkage, Cox regression, linear regression
  • Record linkage
  • Cox regression
  • Linear regression

Main finding

As reported in the abstract

Hazard ratio

1.26

95% CI 1.12–1.42

P < 0.001

PEvs PE-free
HR 1.26 (95% CI 1.12–1.42); P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
Diabetic retinopathy1.22 (1.07–1.38)P = 0.003
CKD1.35 (1.06–1.71)P = 0.016
Diabetic proteinuric kidney disease2.45 (1.03–5.81)P < 0.001

BMI at T2D diagnosis

P < 0.001

Systolic BP at T2D diagnosis

P < 0.001

HDL cholesterol at T2D diagnosis

P = 0.002

Age at CVD

P < 0.001

Age at all-cause death

P < 0.0001

OutcomeDifference (years)P value
Age at T2D diagnosisEarlier with PE3.2P < 0.001

Original publication

Clinical implications of a history of pre‐eclampsia in women with type two diabetes mellitus. Diabet Med. Published 16 April 2025. doi:10.1111/dme.70046

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.